Brenda O'Connell

Senior Director, Translational Science at Bicara Therapeutics

Speaker

With more than a decade of experience spanning the biotech industry, Dr. Brenda O’Connell is a highly accomplished translational scientist, specializing in the field of immuno-oncology. Brenda has a proven track record of using innovative technologies to reveal the mechanistic insights necessary to precisely select patients and deliver life-saving treatments to those that need them most. Brenda serves as Senior Director at Bicara Therapeutics, where she holds responsibility for leading all translational and preclinical research efforts essential to advancing the Bicara clinical development plan.

Prior to joining Bicara Therapeutics, Brenda built a substantial career at Infinity Pharmaceuticals, culminating in her role as director of translational medicine. Brenda received her PhD from Brown University and completed her post-doctoral fellowship at Harvard Medical School prior to joining the biotech industry.